Smith & Nephew (SNN) Debt to Equity (2015 - 2018)

Smith & Nephew (SNN) posted Debt to Equity of $0.3 for Q4 2018, down 3.73% on a QoQ basis from $0.31 in Q4 2017, and down 3.73% year-over-year from $0.31 in Q4 2017.

Smith & Nephew (SNN) has 4 years of Debt to Equity data on file, last reported at $0.3 in Q4 2018.

  • In Q4 2018, Debt to Equity fell 3.73% year-over-year to $0.3; the TTM figure through Dec 2018 stood at $0.3 (down 3.73% YoY), while the FY2018 annual figure was $0.3, down 3.73% from the prior year.
  • Debt to Equity retreated to $0.3 in Q4 2018, from $0.31 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.42 in Q4 2016 and bottomed at $0.3 in Q4 2018.
  • A 4-year average of $0.35 and a median of $0.34 in 2015 frame the typical range for Debt to Equity.
  • Annual changes were most pronounced in 2016 — Debt to Equity rose 11.71% — and 2017, when it slipped 25.1%.
  • Year by year, Debt to Equity stood at $0.37 in 2015, then gained by 11.71% to $0.42 in 2016, then fell by 25.1% to $0.31 in 2017, then declined by 3.73% to $0.3 in 2018.
  • The last three Debt to Equity figures came in at $0.3 (Q4 2018), $0.31 (Q4 2017), and $0.42 (Q4 2016), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.65
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.64
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.57
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.42
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.06
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.95
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.27
10 Smith & Nephew 5.16 Bn 4.58 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2018 0.30
Dec 31, 2017 0.31
Dec 31, 2016 0.42
Dec 31, 2015 0.37